Skip to main content
Erschienen in: Rheumatology International 10/2016

13.07.2016 | Observational Research

HLA B27 typing in 511 children with juvenile idiopathic arthritis from India

verfasst von: Rajni Srivastava, Sanat Phatak, Akhilesh Yadav, Preeti Bajpai, Amita Aggarwal

Erschienen in: Rheumatology International | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

The enthesitis-related arthritis (ERA) category of juvenile idiopathic arthritis (JIA) is the most common category in India. HLA B27 has a high prevalence in ERA, and ILAR classification includes it in exclusion criteria for other categories, but due to its cost, it is not routinely done. We undertook this study to assess the prevalence of HLA B27 in ERA and other groups of juvenile arthritis in India. Consecutive patients of JIA ERA and select patients from other categories were recruited from a single tertiary care hospital over a span of 3 years. HLA B27 was tested using PCR. Five hundred and eleven children were studied: 312 had ERA, and 199 had other categories (29 oligoarthritis, 107 polyarthritis, 44 systemic onset JIA, 9 psoriatic arthritis and 10 undifferentiated). The prevalence of HLA B27 was highest in the ERA group (87 %) and correlated with the presence of sacroiliitis. Prevalence was 10.3 % in oligoarthritis, 16 % in polyarticular rheumatoid factor (RF)-positive arthritis, 26 % in RF-negative polyarticular arthritis, 66 % in psoriatic arthritis and 40 % in the unclassified and 0 % in systemic onset category. Twenty-seven children had a change in category of JIA as per ILAR owing to HLA B27 testing positive, most commonly in the RF-negative polyarthritis group. Only six of these had clinical features suggestive of Spondyloarthropathy. There is high prevalence of HLA B27 in ERA. Though HLA B27 testing helps in correct classification, a minority of these patients have features suggestive of spondyloarthropathy like back pain, enthesitis or sacroiliitis.
Literatur
1.
Zurück zum Zitat Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed
2.
Zurück zum Zitat Kunjir V, Venugopalan A, Chopra A (2010) Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol 37:1756–1762CrossRefPubMed Kunjir V, Venugopalan A, Chopra A (2010) Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol 37:1756–1762CrossRefPubMed
3.
Zurück zum Zitat Hofer M (2006) Spondylarthropathies in children—are they different from those in adults? Best Pract Res Clin Rheumatol 20:315–328CrossRefPubMed Hofer M (2006) Spondylarthropathies in children—are they different from those in adults? Best Pract Res Clin Rheumatol 20:315–328CrossRefPubMed
4.
Zurück zum Zitat Jacobs JC, Berdon WE, Johnston AD (1982) HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients. J Pediatr 100:521–528CrossRefPubMed Jacobs JC, Berdon WE, Johnston AD (1982) HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients. J Pediatr 100:521–528CrossRefPubMed
5.
Zurück zum Zitat Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J (1997) Juvenile-onset spondyloarthropathies. Rheum Dis Clin North Am 23:569–598CrossRefPubMed Burgos-Vargas R, Pacheco-Tena C, Vazquez-Mellado J (1997) Juvenile-onset spondyloarthropathies. Rheum Dis Clin North Am 23:569–598CrossRefPubMed
6.
Zurück zum Zitat Berntson L et al (2008) HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol 35:2055–2061PubMed Berntson L et al (2008) HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol 35:2055–2061PubMed
7.
8.
Zurück zum Zitat Tonks S, Marsh SG, Bunce M, Bodmer JG (1999) Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop. Tissue Antigens 53:175–183CrossRefPubMed Tonks S, Marsh SG, Bunce M, Bodmer JG (1999) Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop. Tissue Antigens 53:175–183CrossRefPubMed
9.
Zurück zum Zitat Shankarkumar U (2003) HLA-B27 allele diversity in Indians: impact of ethnic origin and the caste system. Br J Biomed Sci 60:223–226PubMed Shankarkumar U (2003) HLA-B27 allele diversity in Indians: impact of ethnic origin and the caste system. Br J Biomed Sci 60:223–226PubMed
10.
Zurück zum Zitat Srivastava R, Agnihotry S, Aggarwal R, Bajpai P, Aggarwal A (2015) HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India. Clin Exp Rheumatol 33:931–935PubMed Srivastava R, Agnihotry S, Aggarwal R, Bajpai P, Aggarwal A (2015) HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India. Clin Exp Rheumatol 33:931–935PubMed
11.
Zurück zum Zitat Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809–2818CrossRefPubMed Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809–2818CrossRefPubMed
12.
Zurück zum Zitat Thomson W, Barrett JH, Donn R, Pepper L, Kennedy LJ, Ollier WE, Silman AJ, Woo P, Southwood T, British Paediatric Rheumatology Study Group (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) 41:1183–1189CrossRef Thomson W, Barrett JH, Donn R, Pepper L, Kennedy LJ, Ollier WE, Silman AJ, Woo P, Southwood T, British Paediatric Rheumatology Study Group (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) 41:1183–1189CrossRef
13.
Zurück zum Zitat Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG et al (1986) A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274–281CrossRefPubMed Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG et al (1986) A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274–281CrossRefPubMed
14.
Zurück zum Zitat Gladman DD, Farewell VT, Kopciuk KA, Cook RJ (1998) HLA markers and progression in psoriatic arthritis. J Rheumatol 25:730–733PubMed Gladman DD, Farewell VT, Kopciuk KA, Cook RJ (1998) HLA markers and progression in psoriatic arthritis. J Rheumatol 25:730–733PubMed
15.
Zurück zum Zitat Seipp MT, Erali M, Wies RL, Wittwer C (2005) HLA-B27 typing: evaluation of an allele-specific PCR melting assay and two flow cytometric antigen assays. Cytom B Clin Cytom. 63:10–15CrossRef Seipp MT, Erali M, Wies RL, Wittwer C (2005) HLA-B27 typing: evaluation of an allele-specific PCR melting assay and two flow cytometric antigen assays. Cytom B Clin Cytom. 63:10–15CrossRef
Metadaten
Titel
HLA B27 typing in 511 children with juvenile idiopathic arthritis from India
verfasst von
Rajni Srivastava
Sanat Phatak
Akhilesh Yadav
Preeti Bajpai
Amita Aggarwal
Publikationsdatum
13.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 10/2016
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3529-9

Weitere Artikel der Ausgabe 10/2016

Rheumatology International 10/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.